Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, JapanArticle Published on 2023-03-012023-07-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), [키워드] BNT162b2 COVID-19 Healthcare workers SARS-CoV-2 Third vaccination. [DOI] 10.1016/j.jiac.2022.12.012 PMC 바로가기
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort studyArticle Published on 2023-03-012023-07-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] BNT162b2 ChAdOx1-S heterologous prime-boost immunogenicity Reactogenicity. [DOI] 10.1016/j.ijid.2022.12.034 PMC 바로가기
Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 boosterArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] binding antibodies BNT162b2 COVID-19 mRNA vaccine Neutralizing antibodies omicron SARS-CoV-2 vaccine efficacy. [DOI] 10.1002/jmv.28164 PMC 바로가기
COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach영국 웨일즈에서 50세 이상 성인의 COVID-19 백신 섭취 및 효과: 120만 인구 데이터 연결 코호트 접근법Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI Adult affected Alpha approach BNT162b2 ChAdOx1 ChAdOx1 vaccine ChAdOx1 vaccines Characteristics Cohort collected data Coverage COVID-19 COVID-19 vaccine COVID-19 vaccines death Delta dose doses Effectiveness estimate first dose followed by Hospital admission immunization Infection linkage of BNT162b2 Older outcome outcomes PCR positive PCR positive SARS-CoV-2 infection post vaccination predominant SARS-CoV-2 SARS-COV-2 infection schedule second dose Seven strain vaccination vaccination. Vaccine variants Wales [DOI] 10.1080/21645515.2022.2031774 PMC 바로가기 [Article Type] Article
Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan일본 의료 센터에서 BNT162b2 mRNA COVID-19 백신의 효과 및 돌파구에 대한 실제 증거Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Asia Asian BNT162b2 BNT162b2 vaccine breakthrough COVID-19 vaccine delta variant demonstrated Effectiveness Effectiveness. Evidence evidence of hospital hygiene Infection infection control Japan measure mRNA of BNT162b2 Population populations Public hygiene Regulation required retrospective cohort study SARS-CoV-2 Spread Tokyo vaccination Vaccine variant while [DOI] 10.1080/21645515.2021.1984124 PMC 바로가기 [Article Type] Article
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainArticle Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] Binding assays BNT162b2 ChAdOx1 COVID-19 neutralization tests SARS-CoV-2 sVNT. [DOI] 10.1128/spectrum.02669-22 PMC 바로가기
To vaccinate or not to vaccinate – BNT162b2 seroconversion rate and side effects among Polish healthcare workersArticle Published on 2022-12-152023-07-10 Journal: International journal of occupational medicine and environmental health [Category] COVID19(2023년), [키워드] BNT162b2 COVID-19 healthcare SARS-CoV-2 Side effect vaccination. [DOI] 10.13075/ijomeh.1896.01887 PMC 바로가기
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control studyArticle Published on 2022-12-012023-07-10 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), [키워드] BNT162b2 CoronaVac COVID-19 Omicron BA.2 vaccine effectiveness. [DOI] 10.1080/22221751.2022.2114854 PMC 바로가기
Impact of SARS-CoV-2 Delta and Omicron variants on viral burden and cycle threshold in BNT162b2-vaccinated 12-18 years groupArticle Published on 2022-12-012023-07-10 Journal: Brazilian journal of microbiology : [publication o [Category] COVID19(2023년), [키워드] BNT162b2 COVID-19 Delta omicron pediatrics SARS-CoV-2. [DOI] 10.1007/s42770-022-00820-3 PMC 바로가기
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialArticle Published on 2022-12-012022-10-06 Journal: The Lancet Regional Health - Western Pacific [Category] 진단, [키워드] acute respiratory syndrome Administered Adults adverse event AEs age analysis assessment assigned BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine China Chinese clinical trial Complete Completed conducted coronavirus COVID-19 development dose double-blind Efficacy and safety enrolled Follow-up geometric mean titer GMT GMTs Han Chinese healthy immune response immunogenicity immunogenicity endpoint Inc independent individual injection intramuscular Intramuscular injection investigators Laboratory parameters management messenger Messenger RNA Mild moderate mRNA vaccine Neutralising Antibodies neutralising antibody of BNT162b2 participant Participants pharmaceutical Placebo placebo-controlled trial randomisation randomised Randomly reactogenicity receive recipients recruited reduced remained reported resolved Result robust Safety SARS-CoV-2 SARS-CoV-2 variant SCR second dose sera serious AE seroconversion rate severity Shanghai Sponsor statisticians stratified T-cell Response the placebo group Tolerability Treatment Trial utilised vaccination vaccination. vaccine administration were blinded [DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article